LZAGF News and Press, Lonza Group AG

2024-07-16 09:45:00 ET Summary With inflation slowing in many countries, equity markets saw modest returns in Q2. In a cooling equity market, the portfolio fell short of the MSCI EAFE Index and the MSCI All Country World ex USA Index in Q2. Our holdings in the materials sector...

2024-06-04 16:12:36 ET Summary Medpace Holdings is a US-based clinical research organization that is well-positioned to benefit from increased demand due to geopolitical risks affecting Chinese firms. Medpace stands out among its peers due to its growth orientation, competitive ma...

2024-05-14 13:48:01 ET Lonza Group AG (LZAGY) Q1 2024 Earnings Conference Call May 14, 2024 08:00 ET Company Participants Albert Baehny - Interim Chief Executive Officer & Chairman of the Board of Directors Philippe Deecke - Chief Financial Officer Conferen...

NeuroSense Announces First Quarter 2024 Business Update PR Newswire CAMBRIDGE, Mass. , May 2, 2024 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a company developing novel treatments for severe neurodegenerative diseases, today ...

2024-04-24 10:00:00 ET Summary Artisan Partners is an independent investment management firm focused on providing high value-added, active investment strategies to sophisticated clients globally. The portfolio meaningfully beat the benchmark MSCI EAFE Index, as well as the seconda...

2024-04-24 03:45:00 ET Summary The MSCI ACWI ex-US Index was up 4.69% in the first quarter with a mixture of positive and negative elements. Performance of Economic Sectors were mixed as well. The best performance came from Information Technology while the worst was Consumer Stapl...

2024-04-04 13:20:24 ET Summary Reflecting Lonza's Vacaville acquisition, we increased our sales and EBITDA expectations. The company has an ongoing buyback and a progressive dividend per share. We positively view the new CEO appointment. This removed an overhang of Lonza's equ...

2024-04-02 05:21:07 ET Read the full article on Seeking Alpha For further details see: Lonza appoints new CEO

2024-03-20 06:14:16 ET Swiss contract drug manufacturer Lonza ( OTCPK:LZAGF ) ( OTCPK:LZAGY ) has agreed to acquire a large-scale biologics manufacturing site in California from Roche ( OTCQX:RHHBY ) ( OTCQX:RHHBF ) for $1.2B in cash.... Read the full article on Seekin...

2024-02-11 12:00:03 ET More on Eli Lilly, Novo Nordisk, etc. Will Eli Lilly and Company Become A Trillion-Dollar Baby? Eli Lilly and Company: Even 'Miracle Drugs' Can't Keep Stock Rising (Downgrade) Eli Lilly and Co (LLY) Q4 2023 Earnings Conference Call Transcript ...